Investigating magnesium supplementation effects in diverse patients with diabetes and heart failure
Diversity Supplement
This study is looking at whether taking magnesium supplements can help people with diabetes and heart failure feel better and stay healthier, especially focusing on different racial, ethnic, and gender groups that haven't been studied much before.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10984593 on NIH RePORTER |
What this research studies
This research explores how magnesium supplementation may affect patients with diabetes and heart failure, focusing on differences among various racial, ethnic, and gender groups. It aims to determine if magnesium can reduce the risk of heart failure in diabetic patients and improve outcomes for those already suffering from heart failure. The study will gather data on the safety and effectiveness of magnesium supplements, particularly in populations that have been underrepresented in previous research. By examining patient and provider perspectives, the research seeks to enhance understanding of magnesium use in heart failure management.
Who could benefit from this research
Good fit: Ideal candidates include African American individuals with diabetes and heart failure, as well as other diverse racial and ethnic groups.
Not a fit: Patients without diabetes or heart failure, or those not belonging to the targeted diverse populations, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved heart failure management and prevention strategies tailored to diverse populations.
How similar studies have performed: Previous research has indicated potential benefits of magnesium supplementation in heart failure, but this study aims to provide more targeted insights across diverse populations.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Zeng, Qing — George Washington University
- Study coordinator: Zeng, Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.